Sales 2024 by Business Segment

Sales 2024 by Geography

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Breakdown by Business Segment (GBP)
Fiscal Period: December 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Biological Products

          

Therapeutics

1.62M 2.16M 5.48M 2.06M 113K

Gross Profit

984K 1.46M 5.35M 2.04M 113K

EBITDA

- - -5.84M -13.56M -17.29M

D&A

701K 950K 1.28M 1.28M 1.25M

Operating Income

-8.96M -14.18M -10.98M -17.42M -19.99M

Diagnostics

519K 779K 4.17M 21.19M -

Gross Profit

198K 555K 1.89M 9.2M -

EBITDA

- - -5.12M -1.18M -

D&A

357K 505K 1.66M 2.38M -

Operating Income

-6.6M -10.46M -13.45M -4.43M -

Operating Income

-3.67M -4.44M -8.21M -6.5M -12.57M

EBITDA

- - -4.12M -5.4M -8.91M

D&A

- - 18K 11K 256K

Total Assets

- - - - -

Life Sciences Tools and Services

          

Life Sciences

- - - - -

Total Assets

- - - - -

CAPEX

- - - - -

Gross Profit

- - - - -

EBITDA

- - - - -

D&A

- - - - -

Operating Income

- - - - -

Veterinary Equipment

          

Animal Health

1.49M - - - -

Total Assets

- - - - -

CAPEX

- - - - -

Gross Profit

999K - - - -

EBITDA

- - - - -

D&A

62K - - - -

Operating Income

-2.06M - - - -

Geographical Revenue Distribution History

Geographical breakdown of sales (GBP)
Fiscal Period: December 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

South Korea

- 1.4M 5.48M 2.06M 113K

Rest of World

- - - 613K -

Total Assets

- - - 5.15M -

France

- - 1.3M 4.12M -

Total Assets

- - 2.28M 1.84M -

Rest of Asia

- 74K 7K - -

Rest of Europe

685K 111K 158K 3.69M -

North America

402K 815K 179K 21K -

Asia

1.47M - - - -

Outside The United Kingdom

- - - - -

United Kingdom

1.08M 540K 2.53M 12.75M -

Total Assets

14.21M 12.27M 34.82M 38.17M -